BACKGROUND: Perfusion assessment of the pancreas is challenging and poorly evaluated. Pancreatic affection is a prevalent feature of cystic fibrosis (CF). Little is known about pancreatic perfusion in CF. We aimed to assess pancreatic perfusion by contrast-enhanced ultrasound (CEUS) analysed in the bolus-and-burst model and software. METHODS: We performed contrast enhanced ultrasound of the pancreas in 25 CF patients and 20 healthy controls. Perfusion data was analysed using a dedicated perfusion model providing the mean capillary transit-time (MTT), blood flow (BF) and blood-volume (BV). CF patients were divided according to exocrine function. RESULTS: The pancreas insufficient CF patients had longer MTT (p ≤ 0.002), lower BF (p < 0.001) and lower BV (p < 0.05) compared to the healthy controls and sufficient CF patients. Interrater analysis showed substantial agreement for the analysis of mean transit time. CONCLUSION: The bolus-and-burst method used on pancreatic CEUS-examinations demonstrates reduced perfusion in CF patients with pancreas affection. The perfusion model and software requires further optimization and standardization to be clinical applicable for the assessment of pancreatic perfusion.

Department of Biomedical Engineering Faculty of Electrical Engineering and Communication Brno University of Technology Brno Czech Republic

Department of Clinical Medicine University of Bergen Bergen Norway

Department of Clinical Science University of Bergen Bergen Norway

Department of Medicine National Centre for Ultrasound in Gastroenterology Haukeland University Hospital 5021 Bergen Norway

Department of Medicine Voss Hospital Voss Norway

Institute of Scientific Instruments of the Czech Academy of Sciences Brno Czech Republic

LHL clinics Bergen Bergen Norway

Zobrazit více v PubMed

D'Onofrio M, Zamboni G, Faccioli N, Capelli P, Pozzi MR. Ultrasonography of the pancreas. 4. Contrast-enhanced imaging. Abdom Imaging. 2007;32(2):171–181. doi: 10.1007/s00261-006-9010-6. PubMed DOI

Kersting S, Konopke R, Kersting F, Volk A, Distler M, Bergert H, Saeger HD, Grutzmann R, Bunk A. Quantitative perfusion analysis of transabdominal contrast-enhanced ultrasonography of pancreatic masses and carcinomas. Gastroenterology. 2009;137(6):1903–1911. doi: 10.1053/j.gastro.2009.08.049. PubMed DOI

Matsubara H, Itoh A, Kawashima H, Kasugai T, Ohno E, Ishikawa T, Itoh Y, Nakamura Y, Hiramatsu T, Nakamura M, et al. Dynamic quantitative evaluation of contrast-enhanced endoscopic ultrasonography in the diagnosis of pancreatic diseases. Pancreas. 2011;40(7):1073–1079. doi: 10.1097/MPA.0b013e31821f57b7. PubMed DOI

Piscaglia F, Nolsoe C, Dietrich CF, Cosgrove DO, Gilja OH, Bachmann NM, Albrecht T, Barozzi L, Bertolotto M, Catalano O, et al. The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med. 2012;33(1):33–59. doi: 10.1055/s-0031-1281676. PubMed DOI

Azemoto N, Kumagi T, Yokota T, Hirooka M, Kuroda T, Koizumi M, Ohno Y, Yamanishi H, Abe M, Onji M, et al. Utility of contrast-enhanced transabdominal ultrasonography to diagnose early chronic pancreatitis. Biomed Res Int. 2015;2015:393124. doi: 10.1155/2015/393124. PubMed DOI PMC

Delrue L, Blanckaert P, Mertens D, Van MS, Ceelen W, Duyck P. Tissue perfusion in pathologies of the pancreas: assessment using 128-slice computed tomography. Abdom Imaging. 2012;37(4):595–601. doi: 10.1007/s00261-011-9783-0. PubMed DOI

Tsushima Y, Miyazaki M, Taketomi-Takahashi A, Endo K. Feasibility of measuring human pancreatic perfusion in vivo using imaging techniques. Pancreas. 2011;40(5):747–752. doi: 10.1097/MPA.0b013e318215ac22. PubMed DOI

Bali MA, Metens T, Denolin V, De Maertelaer V, Deviere J, Matos C. Pancreatic perfusion: noninvasive quantitative assessment with dynamic contrast-enhanced MR imaging without and with secretin stimulation in healthy volunteers--initial results. Radiology. 2008;247(1):115–121. doi: 10.1148/radiol.2471070685. PubMed DOI

Ishida H, Makino T, Kobayashi M, Tsuneoka K. Laparoscopic measurement of pancreatic blood flow. Endoscopy. 1983;15(3):107–110. doi: 10.1055/s-2007-1021480. PubMed DOI

Lewis MP, Lo SK, Reber PU, Patel A, Gloor B, Todd KE, Toyama MT, Sherman S, Ashley SW, Reber HA. Endoscopic measurement of pancreatic tissue perfusion in patients with chronic pancreatitis and control patients. Gastrointest Endosc. 2000;51(2):195–199. doi: 10.1016/S0016-5107(00)70417-2. PubMed DOI

Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsoe CP, Piscaglia F, Wilson SR, Barr RG, Chammas MC, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med. 2013;34(1):11–29. PubMed

Nylund K, Jirik R, Mezl M, Leh S, Hausken T, Pfeffer F, Odegaard S, Taxt T, Gilja OH. Quantitative contrast-enhanced ultrasound comparison between inflammatory and fibrotic lesions in patients with Crohn's disease. Ultrasound Med Biol. 2013;39(7):1197–1206. doi: 10.1016/j.ultrasmedbio.2013.01.020. PubMed DOI

Lassau N, Bonastre J, Kind M, Vilgrain V, Lacroix J, Cuinet M, Taieb S, Aziza R, Sarran A, Labbe-Devilliers C, et al. Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study. Invest Radiol. 2014;49(12):794–800. doi: 10.1097/RLI.0000000000000085. PubMed DOI PMC

Saevik F, Nylund K, Hausken T, Odegaard S, Gilja OH. Bowel perfusion measured with dynamic contrast-enhanced ultrasound predicts treatment outcome in patients with Crohn's disease. Inflamm Bowel Dis. 2014;20(11):2029-37. PubMed PMC

D'Onofrio M, Canestrini S, Crosara S, De RR, Pozzi MR. Contrast enhanced ultrasound with quantitative perfusion analysis for objective characterization of pancreatic ductal adenocarcinoma: a feasibility study. World J Radiol. 2014;6(3):31–35. doi: 10.4329/wjr.v6.i3.31. PubMed DOI PMC

Fan Z, Li Y, Yan K, Wu W, Yin S, Yang W, Xing B, Li X, Zhang X. Application of contrast-enhanced ultrasound in the diagnosis of solid pancreatic lesions--a comparison of conventional ultrasound and contrast-enhanced CT. Eur J Radiol. 2013;82(9):1385–1390. doi: 10.1016/j.ejrad.2013.04.016. PubMed DOI

Tranquart F, Mercier L, Frinking P, Gaud E, Arditi M. Perfusion quantification in contrast-enhanced ultrasound (CEUS)--ready for research projects and routine clinical use. Ultraschall in der Medizin (Stuttgart, Germany : 1980) 2012;33(Suppl 1):S31–S38. PubMed

Jirik R, Nylund K, Taxt T, Mézl M, Hausken T, Harabi V, Kol R et al: Parametric ultrasound perfusion analysis combining bolus tracking and replenishment. In: 2012 IEEE International Ultrasonics Symposium: 7–10 Oct. 2012 2012; 2012: 1323–1326.

Jirik R, Nylund K, Gilja OH, Mezl M, Harabis V, Kolar R, Standara M, Taxt T. Ultrasound perfusion analysis combining bolus-tracking and burst-replenishment. IEEE Trans Ultrason Ferroelectr Freq Control. 2013;60(2):310–319. doi: 10.1109/TUFFC.2013.2567. PubMed DOI

Stangeland M, Engjom T, Mezl M, Jirik R, Gilja OH, Dimcevski G, Nylund K: Interobserver variation of the bolus-and-burst method for pancreatic perfusion with dynamic contrast-enhanced ultrasound. Ultrasound Int Open 2017: 3 (3):E99-E106. doi: 10.1055/s-0043-110475. Epub 2017 Sep 12. PubMed PMC

Durie PR, Forstner GG. Pathophysiology of the exocrine pancreas in cystic fibrosis. J R Soc Med. 1989;82(Suppl 16):2–10. PubMed PMC

Kopelman H, Corey M, Gaskin K, Durie P, Weizman Z, Forstner G. Impaired chloride secretion, as well as bicarbonate secretion, underlies the fluid secretory defect in the cystic fibrosis pancreas. Gastroenterology. 1988;95(2):349–355. doi: 10.1016/0016-5085(88)90490-8. PubMed DOI

Kopito LE, Shwachman H. The pancreas in cystic fibrosis: chemical composition and comparative morphology. Pediatr Res. 1976;10(8):742–749. PubMed

Pitkaranta P, Kivisaari L, Nordling S, Nuutinen P, Schroder T. Vascular changes of pancreatic ducts and vessels in acute necrotizing, and in chronic pancreatitis in humans. Int J Pancreatol. 1991;8(1):13–22. PubMed

Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, Durie PR, Legrys VA, Massie J, Parad RB, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008;153(2):S4–S14. doi: 10.1016/j.jpeds.2008.05.005. PubMed DOI PMC

Smyth AR, Bell SC, Bojcin S, Bryon M, Duff A, Flume P, Kashirskaya N, Munck A, Ratjen F, Schwarzenberg SJ, et al. European cystic fibrosis society standards of care: best practice guidelines. J Cystic Fibros. 2014;13(Suppl 1):S23–S42. doi: 10.1016/j.jcf.2014.03.010. PubMed DOI

Schafer S, Nylund K, Saevik F, Engjom T, Mezl M, Jirik R, Dimcevski G, Gilja OH, Tonnies K. Semi-automatic motion compensation of contrast-enhanced ultrasound images from abdominal organs for perfusion analysis. Comput Biol Med. 2015;63:229–237. doi: 10.1016/j.compbiomed.2014.09.014. PubMed DOI

Urbaniak G PS: Research Randomizer (Version 4.0). computer software Available at: https://www.randomizer.org. Accessed 10 May 2018.

Engjom T, Erchinger F, Laerum BN, Tjora E, Aksnes L, Gilja OH, Dimcevski G. Diagnostic accuracy of a short endoscopic secretin test in patients with cystic fibrosis. Pancreas. 2015;44(8):1266–1272. doi: 10.1097/MPA.0000000000000425. PubMed DOI PMC

Erchinger F, Engjom T, Tjora E, Hoem D, Hausken T, Gilja OH, Dimcevski G. Quantification of pancreatic function using a clinically feasible short endoscopic secretin test. Pancreas. 2013;42(7):1101–1106. doi: 10.1097/MPA.0b013e3182847a86. PubMed DOI

Landis J, Koch G. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–174. doi: 10.2307/2529310. PubMed DOI

Gauthier M, Tabarout F, Leguerney I, Polrot M, Pitre S, Peronneau P, Lassau N. Assessment of quantitative perfusion parameters by dynamic contrast-enhanced sonography using a deconvolution method: an in vitro and in vivo study. J Ultrasound Med. 2012;31(4):595–608. doi: 10.7863/jum.2012.31.4.595. PubMed DOI

Engjom T, Erchinger F, Laerum BN, Tjora E, Gilja OH, Dimcevski G. Ultrasound echo-intensity predicts severe pancreatic affection in cystic fibrosis patients. PLoS One. 2015;10(3):e0121121. doi: 10.1371/journal.pone.0121121. PubMed DOI PMC

WMA general assembly 2015. World medical association declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. Available at: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/. Accessed 16 June 2017.